Answers are grounded in this paper and cite their sources.
Giles and Fitzmaurice's arguments are designed to persuade BMJ readers that reporting estimated glomerular filtration rate (eGFR) has introduced a screening programme by the back door, will pressurise specialist services, and cause unnecessary anxiety and harm to patients in terms of getting life insurance and receiving inappropriate treatment.1 The marked increase in referrals of patients with …
No takes yet. Share an insight, caveat, or question.
Tomson et al. (2007) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: